Inventor
HICKEY EUGENE R
US33 patents
⚠️ This page may combine multiple inventors who share the name “HICKEY EUGENE R”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BOEHRINGER INGELHEIM PHARMA
24 patentsUS6358945B1Mar 19, 2002
Compounds useful as anti-inflammatory agents
BOEHRINGER INGELHEIM PHARMA138 citations98
US6080763AJun 27, 2000
Aromatic heterocyclic compounds and their use as anti-inflammatory agents
BOEHRINGER INGELHEIM PHARMA128 citations98
US6492393B1Dec 10, 2002
Compounds useful as anti-inflammatory agents
BOEHRINGER INGELHEIM PHARMA70 citations96
US6297381B1Oct 2, 2001
Aromatic heterocyclic compounds as anti-inflammatory agents
BOEHRINGER INGELHEIM PHARMA55 citations96
US6420364B1Jul 16, 2002
Compound useful as reversible inhibitors of cysteine proteases
BOEHRINGER INGELHEIM PHARMA59 citations95
US7279472B2Oct 9, 2007
Compounds useful as reversible inhibitors of cysteine proteases
BOEHRINGER INGELHEIM PHARMA10 citations92
US6656933B2Dec 2, 2003
Compounds useful as anti-inflammatory agents
BOEHRINGER INGELHEIM PHARMA20 citations92
US6525052B2Feb 25, 2003
Compounds useful as reversible inhibitors of cysteine proteases
BOEHRINGER INGELHEIM PHARMA17 citations92
US6333325B1Dec 25, 2001
Method of treating cytokine mediated diseases or conditions
BOEHRINGER INGELHEIM PHARMA21 citations92
US6242453B1Jun 5, 2001
Polycyclo heterocyclic derivatives as antiinflammatory agents
BOEHRINGER INGELHEIM PHARMA53 citations92
US6228881B1May 8, 2001
Aromatic heterocyclic compounds and their use as anti-inflammatory agents
BOEHRINGER INGELHEIM PHARMA32 citations92
US6660732B2Dec 9, 2003
Compounds useful as anti-inflammatory agents
BOEHRINGER INGELHEIM PHARMA24 citations91
US6720321B2Apr 13, 2004
1,4-disubstituted benzo-fused cycloalkyl urea compounds
BOEHRINGER INGELHEIM PHARMA14 citations84
US6432995B2Aug 13, 2002
Aromatic heterocyclic compounds and their use as anti-inflammatory agents
BOEHRINGER INGELHEIM PHARMA15 citations84
US6858623B2Feb 22, 2005
Compounds useful as reversible inhibitors of cysteine proteases
BOEHRINGER INGELHEIM PHARMA9 citations81
US6506748B2Jan 14, 2003
Aromatic heterocyclic compounds as antiinflammatory agents
BOEHRINGER INGELHEIM PHARMA7 citations74
US7056915B2Jun 6, 2006
Compounds useful as reversible inhibitors of cysteine proteases
BOEHRINGER INGELHEIM PHARMA3 citations73
US6982272B2Jan 3, 2006
Compounds useful as reversible inhibitors of cysteine proteases
BOEHRINGER INGELHEIM PHARMA6 citations73
US6936606B2Aug 30, 2005
Cyanoamido-containing heterocyclic compounds useful as reversible inhibitors of cysteine proteases
BOEHRINGER INGELHEIM PHARMA7 citations62
US6787540B2Sep 7, 2004
Compounds useful as reversible inhibitors of cysteine proteases
BOEHRINGER INGELHEIM PHARMA2 citations62
US7326719B2Feb 5, 2008
Cathepsin S inhibitors
BOEHRINGER INGELHEIM PHARMA0 citations52
US7265132B2Sep 4, 2007
Compounds useful as reversible inhibitors of cysteine proteases
BOEHRINGER INGELHEIM PHARMA0 citations51
US6982263B2Jan 3, 2006
Nitriles useful as reversible inhibitors of cysteine proteases
BOEHRINGER INGELHEIM PHARMA2 citations51
US7465745B2Dec 16, 2008
Cathepsin S inhibitors
BOEHRINGER INGELHEIM PHARMA0 citations48
PETRA PHARMA CORP
4 patentsUS11873295B2Jan 16, 2024
Allosteric chromenone inhibitors of phosphoinositide 3-kinase (PI3K) for the treatment of disease
PETRA PHARMA CORP3 citations65
US11649227B2May 16, 2023
Allosteric chromenone inhibitors of phosphoinositide 3-kinase (PI3K) for the treatment of disease
PETRA PHARMA CORP1 citations53
US12030862B2Jul 9, 2024
Allosteric chromenone inhibitors of phosphoinositide 3-kinase (PI3K) for the treatment of disease
PETRA PHARMA CORP0 citations50
US11878970B2Jan 23, 2024
Allosteric chromenone inhibitors of phosphoinositide 3-kinase (PI3K) for the treatment of disease
PETRA PHARMA CORP0 citations44
HIBERCELL INC
3 patentsUS11667651B2Jun 6, 2023
Aminopyridine derivatives as phosphatidylinositol phosphate kinase inhibitors
HIBERCELL INC1 citations59
US11584763B2Feb 21, 2023
Chromenopyridine derivatives as phosphatidylinositol phosphate kinase inhibitors
HIBERCELL INC0 citations48
US11919902B2Mar 5, 2024
Aryl-bipyridine amine derivatives as phosphatidylinositol phosphate kinase inhibitors
HIBERCELL INC0 citations46